Antibody-drug conjugates: targeted drug delivery for cancer.

By S. Alley, N. Okeley, P. Senter. Current Opinion in Chemical Biology, 2010

642 citations recorded by the source corpus.

Subfields: Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/b26a25f0fac8e5a8900f6b0cb1e92e54494706d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. D. Newman
2. G. Cragg

Citations in the corpus

• Cancer nanomedicine: a review of recent success in drug delivery (2017, background): “Proteindrug conjugated nanoparticles are typically very small (10 nm), allowing the nanoparticle to have a long halflife in vivo and thus facilitating its delivery to the target tumor site [50].”
• NATURAL PRODUCTS: A CONTINUING SOURCE OF NOVEL DRUG LEADS (2013, background): “Alley SC, Okeley NM, Senter PD. Antibody-drug conjugates: Targeted drug delivery for cancer.”